HOME >> BIOLOGY >> NEWS
Most Americans do not expect widespread human cases of avian flu in US in the next year

Boston, MA -- The latest national poll conducted by the Harvard School of Public Health (HSPH) Project on the Public and Biological Security finds that at the moment, the majority of the American public is concerned about the threat of avian flu, but only a small proportion is very concerned. However, should cases of avian flu emerge in poultry or humans in this country, the public reaction could lead to significant disruption of the economy and the health care system.

To see the figures related to this poll, visit http://www.hsph.harvard.edu/press/releases/blendon/Avian_Flu_Charts.ppt

To see the topline, visit http://www.hsph.harvard.edu/press/releases/blendon/Avian_Flu_Release_Topline.doc

Concern about Avian Flu

More than half of Americans (57%) report that they are concerned about the potential spread of bird flu in the United States (Figure 1). However, only 15% are very concerned at the moment. A higher proportion of African Americans report that they are concerned about this than whites (70% versus 54%). Similarly, the majority of Americans are not currently concerned that they or a family member will get avian flu within the next twelve months; only one in five (21%) people are worried about this possibility (Figure 2). Six in ten people are concerned about a pandemic outbreak of avian flu, that is, an outbreak in many countries (62%), but only 20% are very concerned. In addition, the American public does not believe avian flu will ultimately spread widely among wild birds (only 28% think so), poultry (24%), or humans in the United States (14%) in the next 12 months. (Figure 3)

If the U.S. were to experience human cases of the avian flu virus currently circulating in Asia, there would be significant public reaction. If such cases were
'"/>

Contact: Christina Roache
croache@hsph.harvard.edu
617-432-6052
Harvard School of Public Health
24-Feb-2006


Page: 1 2 3 4 5

Related biology news :

1. New clue why MS affects African-Americans differently than Caucasians
2. Slow wave activity during sleep is lower in African-Americans than Caucasians
3. Economic impact of hunger affects all Americans
4. African-Americans at increased risk for earlier preterm births
5. Pills or papayas? Survey finds Americans want healthful foods, not more medicines
6. New diabetes research: Half of Americans have gene that affects how body burns sugar
7. Americans support for embryonic stem cell research declines, VCU Life Sciences survey shows
8. African-Americans with prostate cancer more likely to have family history of prostate, breast cancer
9. MIT survey: Climate change tops Americans environmental concerns
10. Americans less likely to accept evolution than Europeans
11. Americans support free access to research

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Most Americans not expect widespread human cases avian flu the next year

(Date:4/27/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces that its Wocket® ... first week of May, 2015 and will be fulfilling ... Gino Pereira , Chief Executive Officer ... as Wocket® enters the consumer market. We would like ...
(Date:4/20/2015)... PASADENA, Calif. , April 20, 2015 ... San Gabriel Valley to implant a new miniaturized, wireless ... HF System is the first and only FDA-approved heart ... reduce hospital admissions when used by physicians to manage ... a sensor that is implanted in the pulmonary artery ...
(Date:4/14/2015)... 2015  HYPR Corp. today announced it has ... Alliance tm , an industry consortium transforming online ... share technology and collaborate to deliver open specifications ... secure and private, and easier to use. ... protects sensitive user information and eliminates the dependency ...
Breaking Biology News(10 mins):Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3
(Date:5/21/2015)... , May 21, 2015  The EveryLife Foundation ... (R-UT) and Amy Klobuchar (D-MN) ... Accelerating Cures & Treatments, or OPEN ACT. ... patient advocacy organizations, this bipartisan legislation promises to ... medicines to rare disease patients by incentivizing drug ...
(Date:5/21/2015)... W. R. Grace & Co. (NYSE: ... Germany has received good manufacturing practice (GMP) certification ... Pharmaceutical Excipient Council (IPEC) Foundation. , ... FP brand of pharmaceutical grade excipient silica gels ... Bay, Maryland (USA) and Sorocaba, Brazil locations. The ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
(Date:5/21/2015)... May 20, 2015 Research and Markets ... of the "2015 Global Survey on Flow ... The primary goal of this research ... instruments and reagents. Key information the survey seeks ... of flow cytometers, predominantly used applications for flow ...
Breaking Biology Technology:Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Global Survey on Flow Cytometry Adoption Trends 2015 2
Cached News: